	US 11,904,014 B2
	Immunostimulatory compositions
Antoine Carpentier, Paris (FR); and Claire Banissi, Vincennes (FR)
Assigned to ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris (FR); and UNIVERSITÉ Paris 13, Villetaneuse (FR)
Filed by ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, Paris (FR); and UNIVERSITÉ PARIS 13, Villetaneuse (FR)
Filed on Nov. 4, 2020, as Appl. No. 17/089,172.
Application 17/089,172 is a continuation of application No. 15/778,929, granted, now 10,857,227, previously published as PCT/EP2016/078794, filed on Nov. 25, 2016.
Claims priority of application No. 15306887 (EP), filed on Nov. 27, 2015.
Prior Publication US 2021/0060156 A1, Mar. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/385 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/385 (2013.01) [A61K 2039/55511 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6093 (2013.01)]

26 Claims

1. A method for generating an immune response against an antigen in a subject, comprising administering to the subject an immunostimulatory composition comprising an antigen complexed to a melanin, wherein the melanin is in the form of particles of less than 500 nm.